CATX · Perspective Therapeutics, Inc. · Executive Compensation
Market Cap
$320.77M
Shares
114.15M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Former CEO | — | $768,694 |
| Jennifer Streeter | Former COO and VP of HR | $555,695 |
| Former CRDO | — | $514,680 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Former CEO | — | $371,195 |
| Jennifer Streeter | Former COO and VP of HR | $266,349 |
| Former CRDO | — | $253,339 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Joel Sendek | Chief Financial Officer | Appointed | 2025-09-04 |
| Maya Martinez-Davis | member of the Board | Appointed | 2025-09-03 |
| Juan Graham | Chief Financial Officer and principal financial officer | Appointed | 2025-01-06 |
| Mark Austin | co-principal financial officer and principal accounting officer | Terminated | 2024-08-30 |
Key facts
CIK
728387
CUSIP
46489V302
13F (30d)
66 filings
66 filers
Visit website
Investor relations